257 results
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
22 May 24
Unregistered Sales of Equity Securities
4:30pm
ANY PSUs. NOTHING STATED HEREIN IS INTENDED OR WRITTEN TO BE USED, AND CANNOT BE USED, FOR THE PURPOSE OF AVOIDING TAXPAYER PENALTIES.
EXHIBIT 10.2
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
22 May 24
Unregistered Sales of Equity Securities
4:30pm
STOCK UNITS. NOTHING STATED HEREIN IS INTENDED OR WRITTEN TO BE USED, AND CANNOT BE USED, FOR THE PURPOSE OF AVOIDING TAXPAYER PENALTIES.
8.Non
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
. Section headings herein are included herein for convenience of reference only and shall not constitute a part hereof for any other purpose or be given … Borrowing Amount minus (b) Total Revolving Credit Outstandings. In calculating Availability at any time and for any purpose under this Agreement
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
Lifecore continues to work towards the installation and qualification of its high-speed multi-purpose 5-head and 10- head isolator fillers … adjusted EBITDA1 (for purpose of comparison to historical presentations; excluding the impact of corporate overheard which was reported as its own segment
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, Inc. Equity Inducement Plan (the “Plan”) will be effective on the Effective Date.
1.2 The purpose of the Plan is to promote the long-term success … , the Plan seeks to achieve its purpose by providing for discretionary Awards to Key Service Providers in the form of Options (which may constitute
8-K
EX-99.1
rq2uv3hw3dfz
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.2
bfv5m5
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.3
0oevkms4
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
424B3
6yvh7f
9 Jun 23
Prospectus supplement
4:31pm
S-1/A
izbnjuhe2u5ppbmbup
6 Jun 23
IPO registration (amended)
4:54pm
8-K
EX-10.1
m6nq06udbkgzhd
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.6
hbii61i
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.5
5rxklcv3zeg9vot
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.2
8err f65fh2dovcdo
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm